-+ 0.00%
-+ 0.00%
-+ 0.00%

DIAMEDICA THERAPEUTICS ANNOUNCES FIRST PATIENTS DOSED IN PHASE 2 TRIAL OF DM199 FOR THE TREATMENT OF FETAL GROWTH RESTRICTION

Reuters·06/23/2026 12:30:00

Please log in to view news